Yifan Pharmaceutical Co., Ltd. (SHE:002019)

China · Delayed Price · Currency is CNY

9.71

-0.10 (-1.02%)

Jun 18, 2026, 3:04 PM CST

-29.94% (1Y)

Market Cap	10.17B -34.5%
Revenue (ttm)	5.06B -1.9%
Net Income	355.69M -9.5%
EPS	0.29 -10.4%
Shares Out	1.04B
PE Ratio	33.60
Forward PE	26.51
Dividend	0.10 (1.01%)
Ex-Dividend Date	May 29, 2026

Volume	8,738,370
Open	9.92
Previous Close	9.81
Day's Range	9.66 - 9.93
52-Week Range	9.66 - 16.66
Beta	0.57
Analysts	Strong Buy
Price Target	13.00 (+33.88%)
Earnings Date	Aug 14, 2026

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provitamin B5; and active pharmaceutical ingredients. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan P... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 2000

Employees 4,182

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002019

Full Company Profile

Financial Performance

In 2025, Yifan Pharmaceutical's revenue was 5.13 billion, a decrease of -0.52% compared to the previous year's 5.16 billion. Earnings were 402.02 million, an increase of 4.16%.

Financial Statements